Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ameren (AEE) Cash & Equivalents (2016 - 2025)

Ameren (AEE) has 17 years of Cash & Equivalents data on record, last reported at $11.0 million in Q2 2025.

  • For Q2 2025, Cash & Equivalents fell 42.11% year-over-year to $11.0 million; the TTM value through Jun 2025 reached $11.0 million, down 42.11%, while the annual FY2024 figure was $7.0 million, 72.0% down from the prior year.
  • Cash & Equivalents reached $11.0 million in Q2 2025 per AEE's latest filing, up from $7.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $267.0 million in Q2 2021 and bottomed at $7.0 million in Q2 2023.
  • Average Cash & Equivalents over 5 years is $95.0 million, with a median of $85.0 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: tumbled 95.65% in 2023, then surged 171.43% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $155.0 million in 2021, then grew by 16.13% to $180.0 million in 2022, then plummeted by 86.11% to $25.0 million in 2023, then tumbled by 72.0% to $7.0 million in 2024, then surged by 57.14% to $11.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $11.0 million in Q2 2025, $7.0 million in Q4 2024, and $17.0 million in Q3 2024.